ATE112783T1 - Stressprotein aus bakterien. - Google Patents

Stressprotein aus bakterien.

Info

Publication number
ATE112783T1
ATE112783T1 AT91914019T AT91914019T ATE112783T1 AT E112783 T1 ATE112783 T1 AT E112783T1 AT 91914019 T AT91914019 T AT 91914019T AT 91914019 T AT91914019 T AT 91914019T AT E112783 T1 ATE112783 T1 AT E112783T1
Authority
AT
Austria
Prior art keywords
stress protein
corynebacterium
protein
peptide
bacteria
Prior art date
Application number
AT91914019T
Other languages
English (en)
Inventor
James Peter Burnie
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester filed Critical Univ Manchester
Application granted granted Critical
Publication of ATE112783T1 publication Critical patent/ATE112783T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1285—Gram-positive bacteria from Corynebacterium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Rigid Pipes And Flexible Pipes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91914019T 1990-07-25 1991-07-25 Stressprotein aus bakterien. ATE112783T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016315A GB9016315D0 (en) 1990-07-25 1990-07-25 Medicaments

Publications (1)

Publication Number Publication Date
ATE112783T1 true ATE112783T1 (de) 1994-10-15

Family

ID=10679630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91914019T ATE112783T1 (de) 1990-07-25 1991-07-25 Stressprotein aus bakterien.

Country Status (9)

Country Link
US (2) US6040148A (de)
EP (1) EP0494294B1 (de)
JP (1) JP3747057B2 (de)
AT (1) ATE112783T1 (de)
DE (1) DE69104602T2 (de)
DK (1) DK0494294T3 (de)
ES (1) ES2062809T3 (de)
GB (1) GB9016315D0 (de)
WO (1) WO1992001717A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2270076A (en) * 1992-08-18 1994-03-02 Univ Manchester Human HSP 90 Epitopes
US5997873A (en) * 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5750119A (en) * 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5837251A (en) 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
US5935576A (en) * 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5830464A (en) * 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
US5948646A (en) 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
ES2439014T3 (es) 1998-02-20 2014-01-21 The University Of Miami Complejo de péptido antigénico-proteína de choque térmico modificada
WO2001091787A1 (en) 2000-06-02 2001-12-06 University Of Connecticut Health Center Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
RU2335295C2 (ru) 2001-08-20 2008-10-10 Юниверсити Оф Коннектикут Хелт Сентер Способы получения композиций, включающих хитшоковые белки или альфа-2-макроглобулин, пригодных для лечения злокачественной опухоли и инфекционного заболевания
US8475785B2 (en) 2008-03-03 2013-07-02 The University Of Miami Allogeneic cancer cell-based immunotherapy
WO2009117116A2 (en) 2008-03-20 2009-09-24 University Of Miami Heat shock protein gp96 vaccination and methods of using same
KR20170109582A (ko) 2015-02-06 2017-09-29 히트 바이오로직스, 인코퍼레이티드 벡터 공동 발현 백신 및 공동 자극 분자
US11666649B2 (en) 2016-10-11 2023-06-06 University Of Miami Vectors and vaccine cells for immunity against Zika virus
CA3058938A1 (en) 2017-04-04 2018-10-11 Heat Biologics, Inc. Intratumoral vaccination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
GB8915019D0 (en) * 1989-06-30 1989-08-23 Matthews Ruth C Medicaments

Also Published As

Publication number Publication date
DK0494294T3 (da) 1994-11-14
ES2062809T3 (es) 1994-12-16
DE69104602D1 (de) 1994-11-17
WO1992001717A1 (en) 1992-02-06
JPH05503943A (ja) 1993-06-24
EP0494294A1 (de) 1992-07-15
JP3747057B2 (ja) 2006-02-22
EP0494294B1 (de) 1994-10-12
US6040148A (en) 2000-03-21
DE69104602T2 (de) 1995-05-11
GB9016315D0 (en) 1990-09-12
US5985277A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
ATE112783T1 (de) Stressprotein aus bakterien.
Li et al. rOmpA is a critical protein for the adhesion ofRickettsia rickettsiito host cells
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
NO20002413L (no) Antistoffer mot Moraxella proteiner og anvendelse derav, samt sett for pÕvisning av antigen og farmasøytisk preparat som inneholder antistoffer
EA199700248A1 (ru) Выделенный по существу очищенный поверхностный антиген белковой природы neisseria и фрагмент этого антигена
ZA965482B (en) Novel antigen.
ATE204480T1 (de) Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon
DE69532605D1 (de) Peptidfragmente von mikrobiellen stressproteinen und daraus hergestellte pharmazeutische zusammensetzungen für die behandlung und vorbeugung von entzündungserkrankungen
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
ATE287963T1 (de) Pseudomonas exotoxin - myelin basisches protein chimäre proteine
Purven et al. Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody
DE3884316D1 (de) Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung.
EA200100700A1 (ru) Гены и белки и их применение
FI953093A0 (fi) Menetelmiä, joilla voidaan havaita ja hoitaa yksilöitä, joilla on epänormaaleja soluja, jotka ekspressoivat HLA-A2/tyrosinaasi-peptidiantigeenejä
ATE239494T1 (de) Heparin-binding protein zur behandlung von sepsis
SE9001105D0 (sv) New methods foer diagnosis of tuberculosis
ATE422503T1 (de) Rekombinante polypeptide aus mycoplasma und impfstoffe
Zhang et al. The low-molecular-mass, cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar-and species-specific epitopes
Heyermann et al. The heterogeneity of bovine IgG2—V. Differences in the primary structure of bovine IgG2 allotypes
Yarnall et al. Isolation and partial characterization of a type II Fe receptor from a group A streptococcus
Lang et al. Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides
DE69521985D1 (de) Diagnose und behandlung von streptococus oder enterococus infektionen
Cavaillon et al. Mitogenicity of streptococcal extracellular products and antagonism with concanavalin A
Devaux et al. A Conserved Sequence Region of Scorpion Toxins Rendered Immunogenic Induces Broadly Cross‐Reactive, Neutralizing Antibodies

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time